Background Impaired sleep and psychological disorders are increasingly recognised as prevalent comorbidities in patients with primary Sjogren's syndrome (pSS), as well as important contributors of atherosclerosis in the general population. In the current study we sought to explore a potential role of psychological comorbidities in the pronounced atherosclerotic risk of pSS patients. Methods 59 pSS patients fulfilling the ACR/EULAR criteria completed specific validated questionnaires assessing fatigue, depression, anxiety and sleep disturbances. Clinical, laboratory and histopathological characteristics together with traditional risk factors for atherosclerosis were documented in all enrolled patients. Subclinical atherosclerosis defined either as carotid and/or femoral plaque formation or increased Intima Media Thickness (IMT) levels were assessed by Doppler ultrasound. Univariate and multivariate analysis were performed. Results Plaque formation and high IMT levels were detected by ultrasound in 41 (69.5%) out of the 59 pSS patients. In univariate analysis, age and higher triglyceride serum levels were associated with both plaque formation and high IMT levels. Hypertension was associated only with high IMT levels. While increased rates of both state anxiety and impaired sleep were detected in pSS patients with plaque formation in a univariate model, only impaired sleep proved to be independently associated with plaque formation among pSS patients (OR=4.2, 95% CI=1.1-15.6, p=0.03). Conclusion This is the first study showing impaired sleep to confer a significantly higher risk of subclinical atherosclerosis in patients with pSS. Clinicians should take psychological disturbances into account when trying to assess and manage the cardiovascular disease risk of pSS patients. Grants/acknowledgements Dr. T. Karageorgas' work was supported by a State Scholarship Foundation (IKY) Fellowship of Excellence for Postgraduate Studies in Greece-Siemens Programme.
CONTRIBUTION OF MTHFR GENE VARIANTS IN LUPUS RELATED SUBCLINICAL ATHEROSCLEROSIS
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Maira Giannelou, Background Elevated concentrations of homocysteine have been previously identified as an independent risk factor for subclinical atherosclerosis in patients with systemic lupus erythematosus (SLE). Given that heightened homocysteine levels are known to be strongly influenced by genetic factors, in the current study we investigated the contribution of functional polymorphisms of the gene encoding for the enzyme 5,10-methylenetetrahydrofolate reductase (MTHFRC677T and MTHFRA1298C) to atherosclerotic disease characterising SLE patients. Materials and methods 138 consecutive SLE patients, according to the American College of Rheumatology (ACR) classification criteria were included in the study. All patients underwent ultrasound measurement of intima-media thickness scores (IMT) and detection of carotid and/or femoral (C/F) plaque. Clinical, haematological, serological, immunological characteristics, therapeutic regimens and classical risk factors for cardiovascular disease were recorded. Peripheral DNA samples from all SLE patients and 561 age/sex matched apparently healthy volunteers (HC) were genotyped by PCR-based assays for the detection of the MTHFR gene polymorphisms (C677T and A1298C). Data were analysed using univariate and multivariate models (SPSS 21.0) and SNPstats software. Results While no difference in the prevalence of MTHFR677TT and MTHFR1298CC genotypes were detected between SLE patients and HC (19% vs 18.4% and 9.6% vs 11.9%, respectively, p-values>0 .05 for both comparisons), MTHFR677TT variant was detected more frequently in SLE patients with plaque formation and high IMT scores compared to those without (26.8% vs 11.9%, p-value=0.004% and 29% vs 15%, p-value=0.02, respectively) . A similar trend-though non significant-was observed between MTHFR1298CC variant with plaque formation/heightened IMT scores. The presence of either MTHFR1298CC or 677TT was identified as independent risk factor for both the formation of atherosclerotic plaque and high IMT scores [OR (95%) CI: 4.8 (1.00-23.7) and OR (95%) CI: 3.6 (1.00-13.8) respectively], following adjustment for potential cofounders. Conclusions The independent association between the homozygous state for either MTHFR677TT or MTHFR1298CC genetic variants and subclinical atherosclerosis implies genetic influences as potential contributors to the increased burden of atherosclerotic disease characterising SLE.
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